Cantor Fitzgerald Remains Bullish Following 'Healthy' 2Q Results From IBM (IBM)

UBS Remains Neutral on IBM (IBM) Following 2Q15 Results

UBS reiterated a Neutral rating and $170.00 price target on IBM (NYSE: IBM) following its 2Q15 Earnings report. Analyst Steven Milunovich said that IBM reported roughly an in-line top line rather than a substantial disappointment.

Milunovich commented, "The good news is that for the... More

Pre-Open Stock Movers 07/21: (SANM) (HOG) (PNK) Higher; (UNFI) (IBM) (UTX) (TSLA) Lower (more...)

CytRx Corporation (Nasdaq: CYTR) 24.5% LOWER; announced the pricing of its previously announced underwritten public offering. CytRx is offering 9,100,000 shares of common stock at a public offering price of $2.75 per share for gross proceeds of approximately $25.0 million, prior to deducting underwriting discounts and... More

IBM (IBM) Estimates Trimmed, PT Bumped at BMO Capital Post Q2

BMO Capital analyst Keith Bachman reiterated a Market Perform rating while bumping his price target on IBM (NYSE: IBM) to $165.00 (from $163.00) following results after the close. The analyst notes much like software, services margins were very disappointing, though they acknowledge... More

After-Hours Stock Movers 07/20: (SANM) (BSX) (CNI) Higher; (CYTR) (IBM) (SHAK) Lower (more...)

CytRx Corporation (Nasdaq: CYTR) 16% LOWER; announced its intention, subject to market and other conditions, to commence an underwritten public offering of its common stock. CytRx intends to use the net proceeds of the offering to fund clinical trials of its drug candidate... More

Market Wrap: Asian Selling Hits Gold Prices; Lockheed Martin Moves to Acquire Sikorsky; Merger Monday

Market wrap for July 20th

End of the Day: S&P 500 up 1.6 to 2,128.28; Dow Jones up 14.0 to 18,100.41; Nasdaq up 8.7 to 5,218.86

Market Brief: U.S. markets gained as gold prices got hit on Monday amid a sell-off in Asia. Leading the charge higher was a slew of solid quarterly reports from Morgan Stanley, Hasbro, and Halliburton,... More

IBM (IBM) Tops Q2 EPS by 6c

IBM (NYSE: IBM) reported Q2 EPS of $3.84, $0.06 better than the analyst estimate of $3.78. Revenue for the quarter came in at $20.8 billion versus the consensus estimate of $20.95 billion.

Geographic Regions

The Americas second-quarter revenues were $9.8 billion, a decrease of 8 percent (down 2 percent adjusting for currency and the divested System x business) from the 2014 period. Revenues from Europe/Middle East/Africa were $6.6 billion, down 17 percent (up 1 percent adjusting for currency and the divested System x business). Asia-Pacific revenues decreased 19 percent (down 1 percent adjusting for currency and the divested... More

IBM (IBM) Trades Positive into Q2 Report

International Business Machines (NYSE: IBM) is in focus ahead of the company's Q2 report, which is expected out after markets close.

The company is expected to post Q2 EPS of $3.70 with revenue of $20.95 billion, from EPS of $4.32 and revenue of $24.4 billion... More

Trading Radar for 7/20: IBM (IBM), Morgan Stanley (MS), Halliburton (HAL), Hasbro (HAS), Rambus (RMBS) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:

Earnings:

Cal-Maine Foods (Nasdaq: CALM) - consensus EPS $1.04
Community Bank System (NYSE: CBU) - consensus EPS $0.55
Exact Sciences (Nasdaq: EXAS) - consensus loss $0.45
Genuine Parts (NYSE:... More

Microsoft's (MSFT) Buy Rating Reaffirmed at Deutsche Bank

Deutsche Bank affirmed its Buy rating on Microsoft (NASDAQ: MSFT) with a price target of $55. FY16 EPS was raised to $3.03 from $2.94. Comments follow its annual partner/reseller event and come ahead of the company's Q4 results on July 21st. Analyst Karl Keirstead noted Microsoft was pushing to drive actual deployment and usage of Office 365.

"MSFTs messaging... More